Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Shares Outstanding (Diluted Average) (2016 - 2023)

Historic Shares Outstanding (Diluted Average) for Aptevo Therapeutics (APVO) over the last 6 years, with Q3 2023 value amounting to $285886.0.

  • Aptevo Therapeutics' Shares Outstanding (Diluted Average) fell 9438.4% to $285886.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $285886.0, marking a year-over-year decrease of 9438.4%. This contributed to the annual value of $5.1 million for FY2022, which is 885.17% up from last year.
  • According to the latest figures from Q3 2023, Aptevo Therapeutics' Shares Outstanding (Diluted Average) is $285886.0, which was down 9438.4% from $163425.0 recorded in Q2 2023.
  • In the past 5 years, Aptevo Therapeutics' Shares Outstanding (Diluted Average) registered a high of $5.1 million during Q4 2022, and its lowest value of $159597.0 during Q1 2023.
  • Over the past 3 years, Aptevo Therapeutics' median Shares Outstanding (Diluted Average) value was $4.8 million (recorded in 2021), while the average stood at $3.5 million.
  • In the last 5 years, Aptevo Therapeutics' Shares Outstanding (Diluted Average) soared by 1073.08% in 2022 and then plummeted by 9676.76% in 2023.
  • Over the past 3 years, Aptevo Therapeutics' Shares Outstanding (Diluted Average) (Quarter) stood at $4.7 million in 2021, then grew by 8.85% to $5.1 million in 2022, then tumbled by 94.4% to $285886.0 in 2023.
  • Its Shares Outstanding (Diluted Average) was $285886.0 in Q3 2023, compared to $163425.0 in Q2 2023 and $159597.0 in Q1 2023.